MML Investors Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,563
Closed -$339K 1960
2021
Q1
$339K Sell
1,563
-1,688
-52% -$317K ﹤0.01% 1455
2020
Q4
$375K Sell
3,251
-969
-23% -$109K ﹤0.01% 1288
2020
Q3
$411K Buy
4,220
+471
+13% +$54.2K 0.01% 1135
2020
Q2
$460K Buy
3,749
+395
+12% +$44.8K 0.01% 1028
2020
Q1
$294K Sell
3,354
-518
-13% -$54.9K 0.01% 1096
2019
Q4
$405K Buy
3,872
+920
+31% +$103K 0.01% 1097
2019
Q3
$340K Sell
2,952
-3,507
-54% -$532K 0.01% 1122
2019
Q2
$1.11M Buy
6,459
+197
+3% +$34.1K 0.02% 682
2019
Q1
$1.06M Buy
6,262
+771
+14% +$115K 0.02% 682
2018
Q4
$535K Buy
5,491
+552
+11% +$72.4K 0.01% 878
2018
Q3
$853K Buy
4,939
+2,688
+119% +$388K 0.01% 736
2018
Q2
$314K Buy
+2,251
New +$320K 0.01% 1059

Other funds holding GWPH

MML Investors Services's GWPH Position: Q2 2021 in Review

MML Investors Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,563 shares — an estimated $339K sold.

MML Investors Services first reported a position in GWPH in Q2 2018 and held it in 12 quarters. The position peaked at $1.11M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • MML Investors Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • MML Investors Services sold 1,563 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $339K.
  • MML Investors Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 12 quarters.
  • MML Investors Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.11M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on MML Investors Services's 13F filing for Q2 2021, filed 13 Aug 2021.